Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Invesco Biotechnology & Genome ETF PBE

Full chart Compare
Set alert

Price alert · PBE

All alert types
104.31 USD +1.97 (+1.92%)

Nov 4, 2026, 2:21 PM EST

103.10 Day range 104.52
75.10 52-week range 104.52
YTD
+26.98%
1 year
+41.42%

Invesco Biotechnology & Genome ETF

Issuer
Invesco
Asset class
Equity
Expense ratio
0.59%
Assets under management
$442.23M
NAV
102.37
Holdings
31
Inception
2005-06-23
Top 10 weight
49.05%

Top holdings

  1. REGN Regeneron Pharmaceuticals Inc 5.62%
  2. NTRA Natera Inc 5.56%
  3. BIIB Biogen Inc 5.43%
  4. GILD Gilead Sciences Inc 5.42%
  5. RPRX Royalty Pharma PLC 5.15%
  6. ILMN Illumina Inc 5.10%
  7. AMGN Amgen Inc 5.02%
  8. VRTX Vertex Pharmaceuticals Inc 4.62%
  9. MRNA Moderna Inc 3.78%
  10. EXEL Exelixis Inc 3.35%
  11. HALO Halozyme Therapeutics Inc 3.09%
  12. UTHR United Therapeutics Corp 3.05%
  13. QGEN QIAGEN NV 3.03%
  14. VCYT Veracyte Inc 3.00%
  15. TGTX TG Therapeutics Inc 2.88%
  16. NBIX Neurocrine Biosciences Inc 2.82%
  17. NVAX Novavax Inc 2.69%
  18. LEGN Legend Biotech Corp 2.65%
  19. RGEN Repligen Corp 2.58%
  20. SRPT Sarepta Therapeutics Inc 2.57%
  21. VCEL Vericel Corp 2.50%
  22. PTGX Protagonist Therapeutics Inc 2.45%
  23. PTCT PTC Therapeutics Inc 2.44%
  24. INCY Incyte Corp 2.38%
  25. BCRX BioCryst Pharmaceuticals Inc 2.29%

Sector weights

  • Healthcare 99.96%
  • Financial Services 0.04%
  • Cash & Others 0.00%

Country weights

  • United States 100.00%

Updated 2026-11-04

Held by funds

2 US ETFs and mutual funds hold PBE · largest positions

Funds holding PBE, by value held
FundValue heldWeight in fund
DALT $1.50M2.90%
TIH $242.71K0.04%